Polymorphisms in GPC5 also appear to be associated with the response of multiple-sclerosis patients to interferon beta therapy [174], and GPC5 appears to be a risk factor in multiple sclerosis [175]. This evidence concerns the gene GPC5 and multiple sclerosis.